Adial Pharmaceuticals, Inc.
ADIL· Nasdaq
Adial Pharmaceuticals, Inc.
- Last sale
- Oct 2, 2026 · +5.28%
- Market cap
- $11.00M
- 2.63M shares
- Filings
- 561
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,619,671 | reported | |
| FY 2024 | 2024-12-31 | $3,229,226 | reported | |
| FY 2023 | 2023-12-31 | $1,267,077 | reported | |
| FY 2022 | 2022-12-31 | $1,950,308 revised | reported | |
| FY 2021 | 2021-12-31 | $8,395,648 revised | reported | |
| FY 2020 | 2020-12-31 | $5,853,291 | reported | |
| FY 2019 | 2019-12-31 | $3,965,543 | reported | |
| FY 2018 | 2018-12-31 | $368,459 | reported | |
| FY 2017 | 2017-12-31 | $182,107 | reported |
Adial Pharmaceuticals, Inc. · CIK 1513525 · Engraved from SEC EDGAR
